What is the appropriate approach and management for acute‑on‑chronic liver failure due to Wilson's disease in an 8‑year‑old child?

Management of ACLF Wilson's Disease in an 8-Year-Old

An 8-year-old with acute-on-chronic liver failure (ACLF) from Wilson's disease requires immediate referral to a pediatric liver transplant center for urgent evaluation, as liver transplantation is life-saving and often the only effective option for survival 1, 2.

Immediate Actions

1. Urgent Transplant Referral

• Contact a pediatric liver transplant center immediately – clinical deterioration can occur rapidly and unexpectedly 2
• Multidisciplinary team should include pediatric gastroenterologist with liver expertise, intensive care specialist, and liver transplant surgeon 2
• Do not delay referral while attempting medical management

2. Confirm the Diagnosis

In an 8-year-old with ACLF, look for these specific diagnostic clues:

• Coombs-negative hemolytic anemia (highly suggestive when present with ALF) 2
• Low or normal serum alkaline phosphatase (paradoxically low despite liver failure) 2
• Measure serum ceruloplasmin (typically low, but may be falsely normal in acute inflammation)
• 24-hour urinary copper excretion (markedly elevated)
• Slit-lamp examination for Kayser-Fleischer rings 3
• Consider Leipzig scoring system for diagnostic confirmation 4, 5

3. Assess Prognosis

Calculate prognostic scores to determine transplant urgency:

• Nazer score (bilirubin + AST + PT prolongation): score ≥7 indicates non-survival without transplant 1
• Presence of encephalopathy is the strongest predictor of mortality (82% accuracy) 6
• MELD score >30 indicates severe presentation requiring transplant consideration 7

Medical Management (Bridge to Transplant)

Bridging Therapies While Awaiting Transplant

Plasmapheresis/albumin dialysis should be initiated immediately to:

• Remove circulating copper and copper complexes 1
• Protect kidneys from copper-mediated tubular damage 1
• Reduce hemolysis 8
• Stabilize patient temporarily (delays but does not eliminate need for transplant) 1

Molecular Adsorbents Recirculating System (MARS) may be efficacious if available 1

Chelation Therapy

While chelation is standard for chronic Wilson's disease, in ACLF/acute liver failure, chelation alone is insufficient and medical treatment cannot save life 9, 5. However, initiate chelation as adjunctive therapy:

• Trientine 10 mg/kg/day orally (preferred over D-penicillamine in acute settings) 1
• Avoid D-penicillamine as initial therapy in acute liver failure (may worsen neurological symptoms)
• Zinc salts (25 mg elemental zinc in children) can be added, given 5-6 hours apart from chelator 1

Critical caveat: This intensive regimen (chelator + zinc) is investigational and many patients fail this approach, requiring transplantation 1

Supportive ICU Care

Organ Support

• Mechanical ventilation if Grade III-IV encephalopathy develops (for airway protection) 7
• Vasopressors for hemodynamic instability
• Renal replacement therapy if acute kidney injury develops from copper toxicity 1
• Correct coagulopathy (though INR should not be fully corrected as it's needed for prognostic assessment)

Monitor for Complications

• Cerebral edema (contraindication to transplant if uncal herniation occurs) 2
• Multisystem organ failure
• Sepsis (uncontrolled sepsis is contraindication to transplant) 2
• Renal tubular injury from copper deposition

Key Clinical Distinctions

ACLF vs. Fulminant Hepatic Failure

This distinction is critical:

• Fulminant hepatic failure (acute liver failure without known chronic disease) = universally requires transplant 1, 10
• ACLF/decompensated cirrhosis = may respond to intensive medical intervention and avoid transplant 10

In this 8-year-old, the term "ACLF" suggests underlying chronic liver disease (likely cirrhosis) with acute decompensation. However, if encephalopathy is present, prognosis is extremely poor (93.8% mortality) 6, and transplant should be pursued urgently.

Contraindications to Transplant

Do not proceed with transplant if:

• Irreversible cerebral edema with uncal herniation 2
• Severe multisystem disease with very poor prognosis 2, 7
• Uncontrolled sepsis 2

Post-Transplant Considerations

If transplant is successful:

• Copper chelation and zinc therapy are NOT needed after transplant – liver transplantation corrects the underlying metabolic defect 11, 4
• Survival rates: 79-90% at 1 year for chronic presentations 11, 4
• Neurological symptoms may improve but severe pre-existing neurological damage may not fully resolve 11, 4

Algorithm Summary

1. Immediate transplant center referral (do not delay)
2. Confirm diagnosis (hemolytic anemia, low alk phos, ceruloplasmin, urinary copper)
3. Calculate prognostic scores (Nazer ≥7, presence of encephalopathy)
4. Initiate bridging therapies: plasmapheresis/MARS + chelation (trientine 10 mg/kg) + zinc (25 mg elemental, 5-6 hours apart)
5. ICU support: mechanical ventilation, vasopressors, renal replacement as needed
6. Proceed to urgent liver transplantation – this is the definitive life-saving treatment

The bottom line: Medical therapy alone has minimal efficacy in Wilson's disease ACLF. Transplantation is the only reliable path to survival, and time is critical 1, 9, 5.